Market Cap 95.26M
Revenue (ttm) 1.41M
Net Income (ttm) -62.42M
EPS (ttm) N/A
PE Ratio 0.00
Forward PE N/A
Profit Margin -4,426.95%
Debt to Equity Ratio -1.75
Volume 9,494,899
Avg Vol 17,350,115
Day's Range N/A - N/A
Shares Out 148.59M
Stochastic %K 43%
Beta 0.82
Analysts Sell
Price Target $4.90

Company Profile

Outlook Therapeutics, Inc., operates as a clinical-stage biopharmaceutical company, focuses on developing and commercializing monoclonal antibodies for ophthalmic indications. Its lead product candidate is ONS-5010, an ophthalmic bevacizumab product formulation of bevacizumab product candidate that is in Phase-III clinical trial for the treatment of wet age-related macular degeneration and other retina diseases. Outlook Therapeutics, Inc. has collaboration agreements with Cencora. Outlook Therap...

Industry: Biotechnology
Sector: Healthcare
Phone: 609 619 3990
Address:
111 S. Wood Avenue, Unit #100, Iselin, United States
GreenGreen24
GreenGreen24 Aug. 29 at 8:40 PM
$OTLK 😂😂
0 · Reply
Tom2772
Tom2772 Aug. 29 at 8:01 PM
$OTLK $GME $AMC On Saturday that's...
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 5:59 PM
$OTLK Have you heard of anything in general related to wet #AMD and #anticoagulants that’s #newer? https://pmc.ncbi.nlm.nih.gov/articles/PMC10148780/
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 5:55 PM
I like $QQQ! I like $AAPL! I like $VOO! #Eye like $OTLK !
0 · Reply
bazza71
bazza71 Aug. 29 at 4:48 PM
$OTLK no shares left to short. Either shorts will hit us hard on Mon or if positive news then short squeeze upwards. Thoughts please from my more learned bulls
3 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 2:15 PM
0 · Reply
Tom2772
Tom2772 Aug. 29 at 7:59 AM
0 · Reply
Zybbi
Zybbi Aug. 29 at 7:41 AM
$OTLK To be, or not to be – that is the question. I am sorry that the meaning of these words is not understood. In it, Prince Hamlet considers whether it is nobler to passively endure the blows of cruel fate or to confront them and take up the fight. In principle, it is a question of life or death. But it applies just as well to other situations. To fight or not to fight? bullish
1 · Reply
Tom2772
Tom2772 Aug. 29 at 7:41 AM
$OTLK Next good news regarding the team build-up. I’m convinced that this new, highly professional team will fully capitalize on the enormous opportunities ahead and turn them into tremendous success.
1 · Reply
HarveySpecter20
HarveySpecter20 Aug. 29 at 5:39 AM
0 · Reply
Latest News on OTLK
Outlook Therapeutics $100M Spot Secondary re-offered at 99c

2026-08-17T08:45:43.000Z - 12 days ago

Outlook Therapeutics $100M Spot Secondary re-offered at 99c


Outlook Therapeutics 55.6M share Spot Secondary priced at 99c

2026-08-17T08:32:20.000Z - 12 days ago

Outlook Therapeutics 55.6M share Spot Secondary priced at 99c


Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)

2026-08-16T13:40:29.000Z - 13 days ago

Outlook Therapeutics reports Q3 EPS (15c), consensus (8c)


Outlook Therapeutics Earnings Call Transcript: Q3 2026

Aug 14, 2026, 8:30 AM EDT - 15 days ago

Outlook Therapeutics Earnings Call Transcript: Q3 2026


Outlook Therapeutics Earnings release: Q3 2026

Aug 14, 2026, 8:30 AM EDT - 15 days ago

Outlook Therapeutics Earnings release: Q3 2026


Outlook Therapeutics Quarterly report: Q3 2026

Aug 14, 2026, 8:30 AM EDT - 15 days ago

Outlook Therapeutics Quarterly report: Q3 2026


Outlook Therapeutics upgraded to Buy from Neutral at BTIG

2026-07-27T10:15:54.000Z - 4 weeks ago

Outlook Therapeutics upgraded to Buy from Neutral at BTIG


Outlook Therapeutics upgraded to Buy from Neutral at BTIG

2026-07-27T10:11:34.000Z - 4 weeks ago

Outlook Therapeutics upgraded to Buy from Neutral at BTIG


Outlook Therapeutics Inc trading resumes

2026-07-24T19:00:14.000Z - 5 weeks ago

Outlook Therapeutics Inc trading resumes


US FDA approves Outlook Therapeutics' eye disease drug

Jul 24, 2026, 3:00 PM EDT - 5 weeks ago

US FDA approves Outlook Therapeutics' eye disease drug


Outlook Therapeutics Inc trading halted, news pending

2026-07-24T17:35:11.000Z - 5 weeks ago

Outlook Therapeutics Inc trading halted, news pending


Outlook Therapeutics Proxy statement: Proxy filing

Jul 10, 2026, 8:00 AM EDT - 7 weeks ago

Outlook Therapeutics Proxy statement: Proxy filing


Outlook Therapeutics Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Outlook Therapeutics Proxy statement: Proxy filing


Outlook Therapeutics Proxy statement: Proxy filing

Jun 1, 2026, 8:00 AM EDT - 3 months ago

Outlook Therapeutics Proxy statement: Proxy filing


Outlook Therapeutics Proxy statement: Proxy filing

May 22, 2026, 8:00 AM EDT - 3 months ago

Outlook Therapeutics Proxy statement: Proxy filing


Outlook Therapeutics Quarterly report: Q2 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

Outlook Therapeutics Quarterly report: Q2 2026


Outlook Therapeutics Earnings release: Q2 2026

May 15, 2026, 7:00 AM EDT - 3 months ago

Outlook Therapeutics Earnings release: Q2 2026


Outlook Therapeutics Announces Proposed Public Offering

Mar 23, 2026, 5:30 PM EDT - 5 months ago

Outlook Therapeutics Announces Proposed Public Offering


Outlook Therapeutics Quarterly report: Q1 2026

Feb 17, 2026, 8:00 AM EST - 6 months ago

Outlook Therapeutics Quarterly report: Q1 2026


Outlook Therapeutics Earnings release: Q1 2026

Feb 17, 2026, 8:00 AM EST - 6 months ago

Outlook Therapeutics Earnings release: Q1 2026


Outlook Therapeutics Proxy statement: Proxy Filing

Jan 26, 2026, 7:00 AM EST - 7 months ago

Outlook Therapeutics Proxy statement: Proxy Filing


Outlook Therapeutics Proxy statement: Proxy Filing

Jan 26, 2026, 7:00 AM EST - 7 months ago

Outlook Therapeutics Proxy statement: Proxy Filing


Outlook Therapeutics Announces New Employment Inducement Grants

Dec 26, 2025, 5:00 PM EST - 8 months ago

Outlook Therapeutics Announces New Employment Inducement Grants


Outlook Therapeutics Annual report: Q4 2025

Dec 19, 2025, 8:30 AM EST - 9 months ago

Outlook Therapeutics Annual report: Q4 2025


Outlook Therapeutics Earnings release: Q4 2025

Dec 19, 2025, 8:30 AM EST - 9 months ago

Outlook Therapeutics Earnings release: Q4 2025


Outlook Therapeutics Provides Update on Type A Meeting with FDA

Sep 29, 2025, 8:45 AM EDT - 11 months ago

Outlook Therapeutics Provides Update on Type A Meeting with FDA


Outlook Therapeutics Requests Type A Meeting with FDA

Sep 2, 2025, 8:35 AM EDT - 1 year ago

Outlook Therapeutics Requests Type A Meeting with FDA


Outlook Therapeutics Transcript: Status Update

Aug 28, 2025, 8:30 AM EDT - 1 year ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Press release: Status Update

Aug 28, 2025, 8:30 AM EDT - 1 year ago

Outlook Therapeutics Press release: Status Update


Outlook Therapeutics Quarterly report: Q3 2025

Aug 14, 2025, 12:00 AM EDT - 1 year ago

Outlook Therapeutics Quarterly report: Q3 2025


Outlook Therapeutics Earnings release: Q3 2025

Aug 14, 2025, 12:00 AM EDT - 1 year ago

Outlook Therapeutics Earnings release: Q3 2025


Outlook Therapeutics Slides: Corporate Presentation

Jul 1, 2025, 7:00 AM EDT - 1 year ago

Outlook Therapeutics Slides: Corporate Presentation


Outlook Therapeutics Transcript: Status Update

Jun 25, 2025, 12:00 PM EDT - 1 year ago

Outlook Therapeutics Transcript: Status Update


Outlook Therapeutics Earnings release: Q2 2025

May 15, 2025, 12:30 PM EDT - 1 year ago

Outlook Therapeutics Earnings release: Q2 2025


Outlook Therapeutics Quarterly report: Q2 2025

May 15, 2025, 12:30 PM EDT - 1 year ago

Outlook Therapeutics Quarterly report: Q2 2025


GreenGreen24
GreenGreen24 Aug. 29 at 8:40 PM
$OTLK 😂😂
0 · Reply
Tom2772
Tom2772 Aug. 29 at 8:01 PM
$OTLK $GME $AMC On Saturday that's...
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 5:59 PM
$OTLK Have you heard of anything in general related to wet #AMD and #anticoagulants that’s #newer? https://pmc.ncbi.nlm.nih.gov/articles/PMC10148780/
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 5:55 PM
I like $QQQ! I like $AAPL! I like $VOO! #Eye like $OTLK !
0 · Reply
bazza71
bazza71 Aug. 29 at 4:48 PM
$OTLK no shares left to short. Either shorts will hit us hard on Mon or if positive news then short squeeze upwards. Thoughts please from my more learned bulls
3 · Reply
DidYouReadThis
DidYouReadThis Aug. 29 at 2:15 PM
0 · Reply
Tom2772
Tom2772 Aug. 29 at 7:59 AM
0 · Reply
Zybbi
Zybbi Aug. 29 at 7:41 AM
$OTLK To be, or not to be – that is the question. I am sorry that the meaning of these words is not understood. In it, Prince Hamlet considers whether it is nobler to passively endure the blows of cruel fate or to confront them and take up the fight. In principle, it is a question of life or death. But it applies just as well to other situations. To fight or not to fight? bullish
1 · Reply
Tom2772
Tom2772 Aug. 29 at 7:41 AM
$OTLK Next good news regarding the team build-up. I’m convinced that this new, highly professional team will fully capitalize on the enormous opportunities ahead and turn them into tremendous success.
1 · Reply
HarveySpecter20
HarveySpecter20 Aug. 29 at 5:39 AM
0 · Reply
NxtBgThng
NxtBgThng Aug. 29 at 3:59 AM
$OTLK Pretty small potatoes but not a bad add if you are broke 🤷‍♂️
1 · Reply
AnalystLLM
AnalystLLM Aug. 29 at 2:27 AM
$OTLK how many lottery you sell today?
0 · Reply
geegor
geegor Aug. 29 at 1:19 AM
$OTLK For a microcap they spend a lot on payouts for C-suiters, even culling them just after awarding hefty cash bonuses (like Kenyon got and Trenary before him). Total reported/estimated cash severances paid: Trenary: $1,142,906 Evanson: $738.530 Kenyon (est. standard package): ~$732,500 Approx aggregate cash out: ~$2.61 million (excluding COBRA, accrued vacation/PTO, and any equity acceleration value). Kenyon's figure is an estimate based on the latest disclosed base/target. This figure also excludes the unreported exit package for Jedd Comiskey as European commercial head, and the cost of re-hires incl. inducement equity (dilution). Incidentally, Comiskey is now with Mirum Pharma based out of Zurich. Outlook always seems to be paying twice each payday for at least one senior position. No wonder they're always raising. Let's hope for some stability now in Kenyon's wake, and not so much $$ waste on exec turnover. If Jahr goes next that'll be another $1-2 million!
2 · Reply
Zybbi
Zybbi Aug. 28 at 10:34 PM
$OTLK To be, or not to be—that is the question. bullish
0 · Reply
MilkingAlgosEveryMonday
MilkingAlgosEveryMonday Aug. 28 at 10:31 PM
$VG $OTLK over all great day thankful to ’Almighty’.
0 · Reply
Timerider
Timerider Aug. 28 at 10:18 PM
$OTLK Sold a bunch of OPEN today as Gump is keeping housing market frozen despite Kaz efforts, Orangutan can't fk medical as easy , ... on we go
0 · Reply
Timerider
Timerider Aug. 28 at 9:22 PM
$OTLK. Shorts up against a rising tide of sales, they using fear to act as undertoe , I walk beach weekly, no problem for longs to 4.00 Bring the fight to them insiders and retail for a quick bear kill
0 · Reply
IniG
IniG Aug. 28 at 9:21 PM
$OTLK me, ever since I bought OTLK shares 😂
2 · Reply
AnalystLLM
AnalystLLM Aug. 28 at 9:20 PM
$OTLK he stepped down probably a request by buyer to make sure 3-4B deal will have someone to take care before deal closed
0 · Reply
IniG
IniG Aug. 28 at 8:39 PM
$OTLK They're going to make more money than Kenyon could handle, thats why they brought in new one 😎😉
0 · Reply
Zybbi
Zybbi Aug. 28 at 8:22 PM
$OTLK AnalystLLM@ Here’s how it works: make money on the stock market and collect cans in the meantime—you’ll become a millionaire faster!
0 · Reply
DidYouReadThis
DidYouReadThis Aug. 28 at 8:04 PM
0 · Reply